Cite
MLA Citation
W Vincken et al.. “P232 Once-daily co-administration of glycopyrronium and indacaterol via Breezhaler® device improves lung function and symptoms in patients with COPD versus indacaterol alone: the GLOW6 study.” Thorax, vol. 68, n.d., pp. A181–A182. http://access.bl.uk/ark:/81055/vdc_100135130620.0x000028